March 9, 2023 06:50 AM EST
Pharma
Manufacturing

Short sup­ply of com­mon­ly used can­cer drugs rais­es con­cerns among hos­pi­tal phar­ma­cists

Tyler Patchen

News Reporter

Ex­perts who track drug sup­ply and care for can­cer pa­tients say they are watch­ing with con­cern about short­ages of sev­er­al gener­ic drugs that are wide­ly …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times